Apple Owes $184 Million in Interest on $634 Million Patent Loss

Apple must pay $184M in interest on a $634M patent loss to Masimo, ruled by a federal judge. The interest covers Apple Watch sales with heart-rate features, rejecting Apple's windfall argument.

Original reporting
Published Oct 5, 2026, 11:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 11:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Apple Owes $184 Million in Interest on $634 Million Patent Loss — source image
Decision brief

The 30-second read

$AAPLBearishMed
01

Why it matters

The added interest expense increases the total financial burden of the verdict, potentially affecting earnings forecasts.

02

Market read

A material legal liability for Apple could trigger short‑term price pressure and influence sector sentiment.

03

What to watch

Potential for Apple to appeal the interest calculation, which could mitigate the immediate impact.

Relevance 7/10Novelty 8/10Timing: immediate market reaction today

Background

Apple’s patent infringement case with Masimo centers on heart‑rate monitoring technology in Apple Watch.

Company-level read

Ticker impact

$AAPLBearishHigh confidence
Context

Apple must pay an additional $184 million in interest on a $634 million patent verdict against Masimo.

Expected impact

likely downward pressure as the market prices in the added cost

Evidence & confidence

The judgment is a fresh, material legal expense for a large-cap company; investors typically react negatively to unexpected liabilities.

Market effects

May raise concerns for other tech firms facing patent litigation risk.

U.S. equity markets could see modest pullback in the consumer‑electronics segment.

Limited to investors tracking large-cap U.S. tech exposure.

Counterpoint

Some investors may view the verdict as a one‑off legal cost that won’t affect Apple’s long‑term growth.

Key entities

  • Apple Inc.

    U.S. technology company facing the judgment.

  • Masimo Corp.

    Medical technology firm that won the patent verdict.

Related articles

$AAPLMed

Apple (AAPL) Expands Smart Home Ecosystem with New LG Collaborat

Apple (AAPL) announced a partnership with LG Electronics to expand its smart home ecosystem, launching new devices like a doorbell and thermostat on October 13. The move aims to revitalize the HomeKit platform and compete in the smart home market. AAPL's stock is trading at $333.63, 15.9% above its GF Value™ of $287.86, indicating modest overvaluation. The company has a GF Score™ of 95/100, with strong profitability, growth, and momentum, but moderate financial strength.

$AAPLMedAI 8/10

Apple sets Q4 2026 earnings release for November 2

Apple announced it will release Q4 2026 earnings on November 2, with a conference call featuring new CEO John Ternus. The company expects revenue between $111.69B and $113.74B, up 9-11% YoY, despite supply constraints. Gross margin is guided at 47-48%. Results will reflect recent price increases and component cost challenges.

$AAPLMed

Apple must pay Masimo an extra $184M for Apple Watch patent infringement

Apple must pay Masimo an additional $184M in interest for patent infringement related to Apple Watch's blood oxygen feature, on top of the $634M already ordered. Judge rejected Apple's argument against interest, citing Supreme Court guidance. Masimo sought 7% interest, but the judge set it to Masimo's borrowing rate, resulting in $184M after compounding.

$AAPLMed

Monster insider trading alert for Apple stock

Apple insiders, including former CEO Tim Cook and current CEO John Ternus, sold over 250,000 shares on October 2, totaling $87 million. Cook sold 191,753 shares at $332.96, Ternus sold 25,412 shares at $332.94, and SVP Deirdre O’Brien sold 46,389 shares at $333.42. Apple's stock is up 28.60% YTD, outperforming Microsoft and the Nasdaq-100 and S&P500 indices.